Citigroup
RVMD icon

Citigroup’s Revolution Medicines RVMD Stock Holding History

Citigroup’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3M Buy
247,052
+157,310
+175% +$23M 0.02% 770
2026
Q1 		$8.73M Buy
89,742
+44,040
+96% +$4.45M ﹤0.01% 1566
2025
Q4 		$3.64M Buy
45,702
+28,402
+164% +$1.86M ﹤0.01% 2237
2025
Q3 		$808K Sell
17,300
-298,362
-95% -$11.7M ﹤0.01% 3298
2025
Q2 		$11.6M Sell
315,662
-293,726
-48% -$11.3M 0.01% 1286
2025
Q1 		$21.5M Buy
609,388
+340,934
+127% +$13.8M 0.01% 931
2024
Q4 		$11.7M Buy
268,454
+150,516
+128% +$7.6M 0.01% 1274
2024
Q3 		$5.35M Buy
117,938
+59,571
+102% +$2.59M ﹤0.01% 1786
2024
Q2 		$2.27M Sell
58,367
-219,308
-79% -$8.2M ﹤0.01% 2244
2024
Q1 		$8.95M Buy
277,675
+116,634
+72% +$3.46M 0.01% 1319
2023
Q4 		$4.62M Buy
161,041
+63,807
+66% +$1.53M ﹤0.01% 1645
2023
Q3 		$2.69M Sell
97,234
-25,290
-21% -$750K ﹤0.01% 1799
2023
Q2 		$3.28M Sell
122,524
-141,244
-54% -$3.47M ﹤0.01% 1790
2023
Q1 		$5.71M Buy
263,768
+156,876
+147% +$3.86M ﹤0.01% 1438
2022
Q4 		$2.55M Sell
106,892
-138,253
-56% -$2.94M ﹤0.01% 1860
2022
Q3 		$4.83M Buy
245,145
+135,598
+124% +$2.98M ﹤0.01% 1585
2022
Q2 		$2.13M Buy
109,547
+80,987
+284% +$1.58M ﹤0.01% 2055
2022
Q1 		$729K Sell
28,560
-107,298
-79% -$2.34M ﹤0.01% 3225
2021
Q4 		$3.42M Buy
135,858
+62,564
+85% +$1.76M ﹤0.01% 2154
2021
Q3 		$2.02M Sell
73,294
-49,023
-40% -$1.43M ﹤0.01% 2547
2021
Q2 		$3.88M Buy
122,317
+31,314
+34% +$1.09M ﹤0.01% 2132
2021
Q1 		$4.17M Buy
91,003
+80,526
+769% +$3.61M ﹤0.01% 1911
2020
Q4 		$415K Buy
10,477
+7,973
+318% +$315K ﹤0.01% 4368
2020
Q3 		$87K Sell
2,504
-1,648
-40% -$45.6K ﹤0.01% 5222
2020
Q2 		$131K Buy
4,152
+29
+0.7% +$912 ﹤0.01% 5347
2020
Q1 		$90K Buy
+4,123
New +$114K ﹤0.01% 5430

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Citigroup's RVMD Position: Q2 2026 in Review

Citigroup increased its Revolution Medicines (RVMD) stake by 175% in Q2 2026, buying an estimated $23M and bringing the position to 247,052 shares worth $46.3M. The position accounts for 0.02% of the portfolio, ranked #770.

Citigroup first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Citigroup held 247,052 shares of Revolution Medicines worth $46.3M as of Q2 2026.
  • Citigroup bought 157,310 Revolution Medicines shares in Q2 2026, an estimated $23M.
  • Revolution Medicines made up 0.02% of Citigroup's portfolio in Q2 2026, its #770 holding.
  • Citigroup first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.